Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Christian Lingjaerde

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Electrophoresis|February 13, 2002
Adaptive weighted least squares method for the estimation of DNA fragment lengths from agarose gelsAkbar Akbari, Fritz Albregtsen, Ole Christian Lingjaerde
Lifetime Data Analysis|January 12, 2008
Partial least squares Cox regression for genome-wide dataStåle Nygård, Ornulf Borgan, Ole Christian Lingjaerde, et al.
Family Practice|October 13, 2006
Severity of illness and the use of paracetamol in febrile preschool children; a case simulation study of parents' assessmentsPer Lagerløv, Mitchell Loeb, Jorid Slettevoll, et al.
Bioinformatics (Oxford, England)|November 9, 2004
CGH-Explorer: a program for analysis of array-CGH dataOle Christian Lingjaerde, Lars O Baumbusch, Knut Liestøl, et al.
Molecular Oncology|March 12, 2019
The immune microenvironment in non-small cell lung cancer is predictive of prognosis after surgeryÅsa Kristina Öjlert, Ann Rita Halvorsen, Daniel Nebdal, et al.
Genes, Chromosomes & Cancer|October 20, 2005
Statistical dissection of genetic pathways involved in prostate carcinogenesisFranclim R Ribeiro, Chieu B Diep, Carmen Jerónimo, et al.
The Lancet. Oncology|August 7, 2010
The importance of gene-centring microarray dataTherese Sørlie, Eldrid Borgan, Simen Myhre, et al.
Molecular Oncology|August 13, 2019
miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancerEvita Maria Lindholm, Miriam Ragle Aure, Mads Haugland Haugen, et al.
BMC Genomics|January 18, 2006
Multilocus analysis of SNP and metabolic data within a given pathwayVessela N Kristensen, Anya Tsalenko, Jurgen Geisler, et al.
Molecular Oncology|August 23, 2018
Intratumor heterogeneity defines treatment-resistant HER2+ breast tumorsInga H Rye, Anne Trinh, Anna B Saetersdal, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Electrophoresis|February 13, 2002
Adaptive weighted least squares method for the estimation of DNA fragment lengths from agarose gelsAkbar Akbari, Fritz Albregtsen, Ole Christian Lingjaerde
Lifetime Data Analysis|January 12, 2008
Partial least squares Cox regression for genome-wide dataStåle Nygård, Ornulf Borgan, Ole Christian Lingjaerde, et al.
Family Practice|October 13, 2006
Severity of illness and the use of paracetamol in febrile preschool children; a case simulation study of parents' assessmentsPer Lagerløv, Mitchell Loeb, Jorid Slettevoll, et al.
Bioinformatics (Oxford, England)|November 9, 2004
CGH-Explorer: a program for analysis of array-CGH dataOle Christian Lingjaerde, Lars O Baumbusch, Knut Liestøl, et al.
Molecular Oncology|March 12, 2019
The immune microenvironment in non-small cell lung cancer is predictive of prognosis after surgeryÅsa Kristina Öjlert, Ann Rita Halvorsen, Daniel Nebdal, et al.
Genes, Chromosomes & Cancer|October 20, 2005
Statistical dissection of genetic pathways involved in prostate carcinogenesisFranclim R Ribeiro, Chieu B Diep, Carmen Jerónimo, et al.
The Lancet. Oncology|August 7, 2010
The importance of gene-centring microarray dataTherese Sørlie, Eldrid Borgan, Simen Myhre, et al.
Molecular Oncology|August 13, 2019
miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancerEvita Maria Lindholm, Miriam Ragle Aure, Mads Haugland Haugen, et al.
BMC Genomics|January 18, 2006
Multilocus analysis of SNP and metabolic data within a given pathwayVessela N Kristensen, Anya Tsalenko, Jurgen Geisler, et al.
Molecular Oncology|August 23, 2018
Intratumor heterogeneity defines treatment-resistant HER2+ breast tumorsInga H Rye, Anne Trinh, Anna B Saetersdal, et al.
Pageof 3